Cite
Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling.
MLA
Chen, Chaojie, et al. “Ganoderma Lucidum Polysaccharide Inhibits HSC Activation and Liver Fibrosis via Targeting Inflammation, Apoptosis, Cell Cycle, and ECM-Receptor Interaction Mediated by TGF-β/Smad Signaling.” Phytomedicine, vol. 110, Feb. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.phymed.2022.154626.
APA
Chen, C., Chen, J., Wang, Y., Fang, L., Guo, C., Sang, T., Peng, H., Zhao, Q., Chen, S., Lin, X., & Wang, X. (2023). Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling. Phytomedicine, 110, N.PAG. https://doi.org/10.1016/j.phymed.2022.154626
Chicago
Chen, Chaojie, Jiajun Chen, Ying Wang, Liu Fang, Cuiling Guo, Tingting Sang, He Peng, et al. 2023. “Ganoderma Lucidum Polysaccharide Inhibits HSC Activation and Liver Fibrosis via Targeting Inflammation, Apoptosis, Cell Cycle, and ECM-Receptor Interaction Mediated by TGF-β/Smad Signaling.” Phytomedicine 110 (February): N.PAG. doi:10.1016/j.phymed.2022.154626.